首页 > 抗体蛋白 > 抗体
PE/Cyanine5 anti-mouse NK-1.1 Antibody
产品名称:
PE/Cyanine5 anti-mouse NK-1.1 Antibody
产品类别:
抗体
产品编号:
108715
产品应用:
108715
[价格]
规格 价格 库存
25µg ¥ 1414 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
NK-1+ cells from mouse spleen and bone marrow
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1,2, complement-dependent cytotoxicity3, in vivo depletion4,5,9,10, mediation of in vitro redirected lysis6, blocking of NK cell function7, induction of proliferation8, immunohistochemical staining of frozen sections11, immunofluorescence microscopy11, and spatial biology (IBEX)16,17. The LEAF? purified antibody (Endotoxin <0.1 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 108712).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy5 to PE/Cyanine5. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine5 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Carlyle JR, et al. 1999. J. Immunol. 162:5917. (IP)
  2. Sentman CL, et al. 1989. Hybridoma 8:605. (IP)
  3. Koo GC, et al. 1984. Hybridoma 3:301. (Cyt)
  4. Sentman CL, et al. 1989. J. Immunol. 142:1847. (Deplete)
  5. Koo GC, et al. 1986. J. Immunol. 137:3742. (Deplete)
  6. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  7. Kung SK, et al. 1999. J. Immunol. 162:5876. (Block)
  8. Reichlin A, et al. 1998. Immunol. Cell Biol. 76:143.
  9. Drobyski W, et al. 1996. Blood 87:5355. (Deplete)
  10. Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (Deplete)
  11. Kanwar JR, et al. 2001. J. Natl. Cancer Inst. 93:1541. (IHC, IF)
  12. Kroemer A, et al. 2008. J. Immunol. 180:7818. PubMed
  13. Kim JY, et al. 2009. Exp Mol Med. 30:288. PubMed
  14. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  15. Lee H, et al. 2014. Invest Ophthalmol Vis Sci. 55:2885. PubMed
  16. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  17. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Lopez-Guadamillas E, et al. 2016. Sci Rep. 6:34542. PubMed
  2. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  3. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  4. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  5. Marangoni F, et al. 2021. Cell. . PubMed
  6. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  7. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  8. Verboom L, et al. 2020. Cell Rep. 30:2237. PubMed
  9. Mamedov MR, et al. 2018. Immunity. 48:350. PubMed
  10. Baier FA, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:745. PubMed
  11. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  12. Guilliams M, et al. 2022. Cell. 185:379. PubMed
  13. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  14. Remmerie A, et al. 2020. Immunity. 53:641. PubMed
  15. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  16. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  17. Fushimi S, et al. 2009. Clin Immunol. 133:437. PubMed
  18. Issah Y, et al. 2021. Elife. 10:. PubMed
  19. S?wen P et al. 2018. eLife. 7 pii: e41258. PubMed
  20. Miao Y et al. 2019. Cell. 177(5):1172-1186 . PubMed
  21. Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
  22. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  23. Henkle TR, et al. 2021. Cancer Res. 81:4560. PubMed
  24. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  25. Tripathi D, et al. 2016. Nat Commun. 7:13896. PubMed
RRID
AB_493591 (BioLegend Cat. No. 108715) AB_493590 (BioLegend Cat. No. 108716)

Antigen Details

Structure
NKR-P1 gene family
Distribution

NK and NK-T cells in the NK1.1 mouse strains (C57BL, FVB/N, NZB)

Function
NK cell activation, IFN-γ production, cytotoxic granule release
Cell Type
NK cells, NKT cells
Biology Area
Immunology, Innate Immunity
Antigen References

1. Lanier LL. 1997. Immunity 6:371.
2. Yokoyama WM, et al. 1993. Ann. Rev. Immunol. 11:613.
3. Koo GC, et al. 1986. J. Immunol. 137:3742.
4. Giorda R, et al. 1991. J. Immunol. 147:1701.

Gene ID
17059 View all products for this Gene ID
UniProt
View information about NK-1.1 on UniProt.org

联系我们

TEL:021-34661275  点击拨打热线